Glutathione-enriched baker's yeast: Production, bioaccessibility and intestinal transport assays

Journal of Applied Microbiology

Volumn 116, Issue 2, 2014, Pages 304-313

  Musatti, A ^a   Devesa, V ^b   Calatayud, M ^b   Velez D ^b   Manzoni, M ^a   Rollini, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Caco 2; Gastrointestinal digestion; Glutathione; HT29 MTX; Intestinal absorption; Yeast

Indexed keywords

BIOMASS; CELL CULTURE; CELLS; PEPTIDES;

BAKER'S YEAST; CACO-2; CELL VIABILITY; GASTROINTESTINAL DIGESTION; GLUTHATHIONE; HT29-MTX; IN-VITRO; INTESTINAL ABSORPTION; INTESTINAL CELLS; TRANSPORT ASSAYS;

YEAST;

ADENINE; GLUCOSE; GLUTATHIONE; CYSTEINYLGLYCINE; DIPEPTIDE;

ABSORPTION; BIOMASS; BIOTRANSFORMATION; DIGESTION; YEAST;

ARTICLE; BIOMASS PRODUCTION; BIOTRANSFORMATION; CELL STRAIN CACO 2; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; FUNGAL CELL; IN VITRO STUDY; INCUBATION TIME; INTESTINE ABSORPTION; INTESTINE CELL; NONHUMAN; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE; SOLUBILIZATION; BIOAVAILABILITY; CACO 2 CELL LINE; CELL SURVIVAL; COCULTURE; CYTOLOGY; DIGESTION; DRIED YEAST; FREEZE DRYING; HT 29 CELL LINE; HUMAN; INTESTINE; INTESTINE MUCOSA; METABOLISM; OXIDATIVE STRESS; PERMEABILITY; TRANSPORT AT THE CELLULAR LEVEL;

SACCHAROMYCES CEREVISIAE;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CACO-2 CELLS; CELL SURVIVAL; COCULTURE TECHNIQUES; DIGESTION; DIPEPTIDES; FREEZE DRYING; GLUTATHIONE; HT29 CELLS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; OXIDATIVE STRESS; PERMEABILITY; SACCHAROMYCES CEREVISIAE; YEAST, DRIED;

EID: 84892497105     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12363     Document Type: Article

References (33)

1. Anderson, M.E. (1998) Glutathione: an overview of biosynthesis and modulation. Chem.-Biol Interact 111, 1-14.
2. Au, A.P. and Reddy, M.R. (2000) Caco-2 cells can be used to assess human iron bioavailability from a semipurified meal. J Nutr 130, 1329-1334.
3. Ault, J.G. and Lawrence, D.A. (2003) Glutathione distribution in normal and oxidatively stressed cells. Exp Cell Res 285, 9-14.
4. Aw, T.Y., Wierzbicka, G. and Jones, D.P. (1991) Oral glutathione increases tissue GSH in vivo. Chem-Biol Interact 80, 89-97.
5. Bekatorou, A., Psarianos, C. and Koutinas, A.A. (2006) Production of food grade yeasts. Food Technol Biotech 44, 407-415.
6. Calatayud, M., Gimeno, J., Vélez, D., Devesa, V. and Montoro, R. (2010) Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line. Chem Res Toxicol 23, 547-556.
7. Commission Regulation (EC) (2009) 1170/2009 amending Directive 2002/46/EC of the European Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards the lists of vitamin and minerals and their forms that can be added to foods, including food supplements. Off J Eur Union, L314, 36-42.
8. Couto, M.R., Gonçalves, P., Catarino, T.M., Araújo, J.R., Correia-Branco, A. and Martel, F. (2012) The effect of oxidative stress upon the intestinal uptake of folic acid: in vitro studies with Caco-2 cells. Cell Biol Toxicol 28, 369-381.
9. Hagen, T.M., Wierzbicka, G.T., Sillau, A.H., Bowman, B.B. and Jones, D.P. (1990) Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol 259, G524-G529.
10. Hidalgo, I.J., Raub, T.J. and Borchardt, R.T. (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736-749.
11. Laparra, J.M., Vélez, D., Montoro, R., Barberá, R. and Farré, R. (2003) Estimation of arsenic bioaccessibility in edible seaweed by an in vitro digestion method. J Agric Food Chem 51, 6080-6085.
12. Lesuffleur, T., Barbat, A., Dussaulx, E. and Zweibaum, A. (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50, 6334-6343.
13. Li, Y., Wei, G. and Chen, J. (2004) Glutathione: a review on biotechnological production. Appl Microbiol Biotechnol 66, 233-242.
14. 2-induced oxidative stresses in Candida utilis. Bioresour Technol 100, 350-355.
15. Liang, G., Mo, Y. and Du, G. (2010) Optimization of sodium dodecyl sulfate (SDS) addition coupled with adenosine triphosphate (ATP) regeneration for glutathione overproduction in high density cultivation of Candida utilis. Enzyme Microb Tech 46, 526-533.
16. Maubon, N., Le Vee, M., Fossati, L., Audry, M., Le Ferrec, E., Bolze, S. and Fardel, O. (2007) Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam Clin Pharmacol 21, 659-663.
17. Microsoft (2003) Microsoft Excel (computer software). Redmond, Washington.
18. Musatti, A., Manzoni, M. and Rollini, M. (2013) Post-fermentative production of glutathione by baker's yeast (S. cerevisiae) in compressed and dried forms. New Biotechnol 30, 219-226.
19. Nisamedtinov, I., Kevvai, K., Orumets, K., Rautio, J.J. and Paalme, T. (2010) Glutathione accumulation in ethanol-stat fed-batch culture of Saccharomyces cerevisiae with a switch to cysteine feeding. Appl Microbiol Biotechnol 87, 175-183.
20. O'Brien, J., Wilson, I., Orton, T. and Pognan, F. (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421-5426.
21. Perricone, C., De Carolis, C. and Perricone, R. (2009) Glutathione: a key player in autoimmunity. Autoimmun Rev 8, 697-701.
22. Rahman, I. and MacNee, W. (1992) Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol Lung Cell Mol Physiol 77, L1067-L1088.
23. Rocha, R.A., Gimeno-Alcañiz, J.V., Martín-Ibañez, R., Canals, J.M., Vélez, D. and Devesa, V. (2011) Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicol Lett 203, 237-244.
24. Rollini, M., Musatti, A., Erba, D., Benedetti, A., Girardo, F. and Manzoni, M. (2011) Process for obtaining copper-enriched cells of Saccharomyces cerevisiae. Process Biochem 46, 1417-1422.
25. Townsend, D.M., Tew, K.D. and Tapiero, H. (2003) The importance of glutathione in human disease. Biomed Pharmacother 57, 145-155.
26. Wang, Z., Tan, T. and Song, J. (2007) Effect of amino acids addition and feedback control strategies on the high-cell-density cultivation of Saccharomyces cerevisiae for glutathione production. Process Biochem 42, 108-111.
27. Wei, G.Y., Wang, D.H. and Chen, J. (2008) Overproduction of glutathione by L-cysteine addition and a temperature shift strategy. Biotechnol Bioproc Eng 13, 347-353.
28. Wen, S., Zhang, T. and Tan, T. (2005) Optimization of the amino acid composition in glutathione fermentation. Process Biochem 40, 3474-3479.
29. Witschi, A., Reddy, S., Stofer, B. and Lauterburg, B.H. (1992) The systemic availability of oral glutathione. Eur J Clin Pharmacol 43, 667-669.
30. Wu, G., Fang, Y.Z., Yang, S., Lupton, J.R. and Turner, N.D. (2004) Glutathione metabolism and its implications for health. J Nutr 134, 489-492.
31. Yamada, E.A. and Sgarbieri, V.C. (2005) Yeast (Saccharomyces cerevisiae) protein concentrate: preparation, chemical composition, and nutritional and functional properties. J Agric Food Chem 53, 3931-3936.
32. Yee, S. (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res 14, 763-766.
33. Yoshida, M., Fukunaga, K., Tsuchita, H. and Yasumoto, K. (1999) An evaluation of the bioavailability of selenium in high-selenium yeast. J Nutr Sci Vitaminol 45, 119-128.